INTRAHEPATIC OVEREXPRESSION OF FOXO1 IN CIRRHOTIC PATIENTS IS A POTENTIAL MARKER OF LIVER INJURY PROGRESSION

被引：0
|
作者：
Fernandez, Esther [1 ]
Sandalinas, Silvia [1 ]
Macias, Laura [1 ]
Portoles-Plaza, Irene [1 ]
Ribera, Jordi [1 ,2 ]
Morales-Romero, Blai [1 ]
Casals, Gregori [1 ,2 ,3 ]
Boix, Loreto [4 ]
Jimenez Povedano, Wladimiro [1 ,2 ,5 ]
Morales-Ruiz, Manuel [1 ,2 ,3 ,5 ]
机构：
[1] Hosp Clin Barcelona, Idibaps, Serv Biochem & Mol Genet, Barcelona, Spain
[2] Ciberehd, Madrid, Spain
[3] Seqc ML, Commiss Biochem Assessment Hepat Dis, Barcelona, Spain
[4] Univ Barcelona, Hosp Clin, Idibaps,Ciberehd, Barcelona Clin Liver Canc Grp,Liver Unit, Barcelona, Spain
[5] Univ Barcelona, Biomed Sch Med & Hlth Sci, Barcelona, Spain
来源：
HEPATOLOGY | 2022年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
3630
引用
收藏
页码：S1148 / S1149
页数：2
相关论文
共 50 条
  • [1] Liver FoxO1 overexpression is positively associated with the degree of liver injury in cirrhotic patients
    Fernandez-Galan, Esther
    Sandalinas, Silvia
    Macias-Munoz, Laura
    Portoles, Irene
    Ribera, Jordi
    Morales-Romero, Blai
    Pauta, Montse
    Casals, Gregori
    Boix, Loreto
    Jimenez, Wladimiro
    Morales-Ruiz, Manuel
    ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO, 2023, 4 (03): : 218 - 226
  • [2] Overexpression of FoxO1 in the liver is positively associated with the degree of liver damage in cirrhotic patients
    Fernandez-Galan, Esther
    Sandalinas, Silvia
    Macias-Munoz, Laura
    Portoles, Irene
    Ribera, Jordi
    Morales-Romero, Blai
    Pauta, Montse
    Casals, Gregori
    Boix, Loreto
    Jimenez, Wladimiro
    Morales-Ruiz, Manuel
    ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO, 2023, 4 (03): : 227 - 235
  • [3] Role of FOXO1 in the progression of Keratoconus.
    Shinde, Vishal
    Foster, James W.
    Daoud, Yassine Jamil
    Jun, Albert
    Chakravarti, Shukti
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [4] Aberrant foxo1 expression is associated with intrahepatic fat deposition and impaired insulin action in liver
    Altomonte, J
    Qu, S
    Dong, HJH
    DIABETES, 2005, 54 : A334 - A334
  • [5] The regulation of FOXO1 and its role in disease progression
    Xing, Ya-qi
    Li, Ang
    Yang, Yang
    Li, Xiao-xia
    Zhang, Li-nan
    Guo, Hui-cai
    LIFE SCIENCES, 2018, 193 : 124 - 131
  • [6] FoxO1 overexpression reduces Aβ production and tau phosphorylation in vitro
    Zhang, Wei
    Bai, Shanshan
    Yang, Jianhua
    Zhang, Yimin
    Liu, Youcai
    Nie, Junjiu
    Meng, Dongli
    Shi, Ruling
    Yao, Zhaoyang
    Wang, Mingyong
    Wang, Hecheng
    Li, Cuiping
    NEUROSCIENCE LETTERS, 2020, 738
  • [7] FOXO1/3: Potential suppressors of fibrosis
    Xin, Zhenlong
    Ma, Zhiqiang
    Hu, Wei
    Jiang, Shuai
    Yang, Zhi
    Li, Tian
    Chen, Fulin
    Jia, Guozhan
    Yang, Yang
    AGEING RESEARCH REVIEWS, 2018, 41 : 42 - 52
  • [8] FOXO1: A Potential Target for Human Diseases
    Lu, Huarui
    Huang, Haojie
    CURRENT DRUG TARGETS, 2011, 12 (09) : 1235 - 1244
  • [9] Effects of FoxO1 on podocyte injury in diabetic rats
    Guo, Feng
    Zhang, Yuanyuan
    Wang, Qingzhu
    Ren, Lei
    Zhou, Yingni
    Ma, Xiaojun
    Wu, Lina
    Qin, Guijun
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 466 (02) : 260 - 266
  • [10] Dual regulation of TxNIP by ChREBP and FoxO1 in liver
    Noblet, Benedicte
    Benhamed, Fadila
    O-Sullivan, Insug
    Zhang, Wenwei
    Filhoulaud, Gaelle
    Montagner, Alexandra
    Polizzi, Arnaud
    Marmier, Solenne
    Burnol, Anne-Francoise
    Guilmeau, Sandra
    Issad, Tarik
    Guillou, Herve
    Bernard, Catherine
    Unterman, Terry
    Postic, Catherine
    ISCIENCE, 2021, 24 (03)
12345